Product Information
HYDROCORTISONE SS 100 MG VIAL is a generic product labeled by Cipla USA Inc., priced at $14.6171 per EA under NDC 69097000467. Its NADAC has been published 76 times since Apr 23, 2025.
FDA first approved this application on Sep 5, 2024. Its Orange Book therapeutic-equivalence code is AP.
Strength
100 mg/2mL
Manufacturer
Cipla USA Inc.NDC
69097000467
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
HYDROCORTISONE SODIUM SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA214050FDA Approved
9/5/2024
TE Code
AP
On Market Since
9/25/2024
Pharmacological Classes
Price Statistics
The NADAC for HYDROCORTISONE SS 100 MG VIAL has been published 76 times since Apr 23, 2025, and over the history we have for it it has declined 3.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.6171 per EA |
|---|---|
| All-time high | $15.2150 (Aug 13, 2025) |
| All-time low | $14.6090 (Jan 21, 2026) |
| 52-week high | $15.1314 |
| 52-week low | $14.6090 |
| Median price | $15.0788 |
| Average price | $14.9750 |
| Largest weekly change | -1.9% (Sep 23, 2026) |
| Weeks tracked | 76 |
| Tracking since | Apr 23, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Hydrocortisone sodium succinate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Hydrocortisone sodium succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDROCORTISONE SS 100 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCORTISONE SS 100 MG VIAL, manufactured by Cipla USA Inc., is $14.6171 per EA (NDC 69097000467), effective Sep 30, 2026.
How has the price of HYDROCORTISONE SS 100 MG VIAL changed over time?
Over the history we have for it, the NADAC for HYDROCORTISONE SS 100 MG VIAL has declined 3.2%. It has been tracked across 76 weekly CMS publications since Apr 23, 2025.
What are the highest and lowest recorded NADAC prices for HYDROCORTISONE SS 100 MG VIAL?
Since Apr 23, 2025, the NADAC for HYDROCORTISONE SS 100 MG VIAL has ranged from a low of $14.6090 (Jan 21, 2026) to a high of $15.2150 (Aug 13, 2025), with a median of $15.0788 per EA.
Are there cheaper alternatives to HYDROCORTISONE SS 100 MG VIAL?
No other NADAC-published product currently shares the active ingredient and strength of HYDROCORTISONE SS 100 MG VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROCORTISONE SS 100 MG VIAL?
HYDROCORTISONE SS 100 MG VIAL (NDC 69097000467) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.